Trends and recent developments in pharmacotherapy of acute pancreatitis

References

• Sarner M. Pancreatitis definitions and classification. In: Go V, DiMagno EP, Gardner JD, et al. editors. The pancreas: biology, pathobiology, and disease. New York (NY): Raven Press Ltd; 1993. p. 575–580.
   Google Scholar
• Gloor B, Müller CA, Worni M, et al. Late mortality in patients with severe acute pancreatitis. Br J Surg. 2001;88(7):975–979.
   PubMed Web of Science ®Google Scholar
• Carnovale A, Rabitti PG, Manes G, et al. Mortality in acute pancreatitis: is it an early or a late event? JOP. 2005;6(5):438–444.
   PubMedGoogle Scholar
• Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006;33(4):323–330.
   PubMed Web of Science ®Google Scholar
• Pancreatitis NICE Guideline [Internet]. United Kingdom: National Institute for Health and Care Excellence; 2018 [cited 2021 Oct 28]. Available from: https://www.nice.org.uk/guidance/ng104/resources/pancreatitis-pdf-66141537952453
   Google Scholar
• Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis: the increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol. 2019;13(6):947–953.e1.
   PubMed Web of Science ®Google Scholar
• Johnson CD, Besselink MG, Carter R. Acute pancreatitis. BMJ. 2014;349(aug12):g4859.
   PubMed Web of Science ®Google Scholar
• Li CL, Jiang M, Pan CQ, et al. The global, regional, and national burden of acute pancreatitis in 204 countries and territories, 1990-2019. BMC Gastroenterol. 2021;21(1):332.
   PubMed Web of Science ®Google Scholar
• Xiao AY, Tan ML, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1(1):45–55.
   PubMed Web of Science ®Google Scholar
• Gapp J, Hall AG, Walters RW, et al. Trends and outcomes of hospitalizations related to acute pancreatitis: epidemiology from 2001 to 2014 in the United States. Pancreas. 2019;48(4):548–554.
   PubMed Web of Science ®Google Scholar
• Roberts SE, Morrison-Rees S, John A, et al. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017;17(2):155–165.
   PubMed Web of Science ®Google Scholar
• Schepers NJ, Bakker OJ, Besselink MG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis. Gut. 2019;68(6):1044–1051.
   PubMed Web of Science ®Google Scholar
• de Sá T C, Soares C, Rocha M. Acute pancreatitis and COVID-19: a literature review. World J Gastrointest Surg. 2021;13(6):574–584.
   PubMed Web of Science ®Google Scholar
• Szatmary P, Arora A, Thomas Raraty MG, et al. Emerging phenotype of severe acute respiratory syndrome-Coronavirus 2-associated pancreatitis. Gastroenterology. 2020;159(4):1551–1554.
   PubMed Web of Science ®Google Scholar
• Akarsu C, Karabulut M, Aydin H, et al. Association between acute pancreatitis and COVID-19: could pancreatitis be the missing piece of the puzzle about increased mortality rates? J Invest Surg. 2022; 35(1):119–125.
   PubMed Web of Science ®Google Scholar
• de-Madaria E, Capurso G. COVID-19 and acute pancreatitis: examining the causality. Nat Rev Gastroenterol Hepatol. 2021;18(1):3–4.
   PubMed Web of Science ®Google Scholar
• Lee WS, Huang JF, Chuang WL. Outcome assessment in acute pancreatitis patients. Kaohsiung J Med Sci. 2013;29(9):469–477.
   PubMed Web of Science ®Google Scholar
• Yang ZW, Meng XX, Xu P. Central role of neutrophil in the pathogenesis of severe acute pancreatitis. J Cell Mol Med. 2015;19(11):2513–2520.
   PubMed Web of Science ®Google Scholar
• Abdulla A, Awla D, Thorlacius H, et al. Role of neutrophils in the activation of trypsinogen in severe acute pancreatitis. J Leukoc Biol. 2011;90(5):975–982.
   PubMed Web of Science ®Google Scholar
• Chen G, Xu F, Li J, et al. Depletion of neutrophils protects against L-arginine-induced acute pancreatitis in mice. Cell Physiol Biochem. 2015;35(6):2111–2120.
   PubMedGoogle Scholar
• Liu LR, Xia SH. Role of platelet-activating factor in the pathogenesis of acute pancreatitis. World J Gastroenterol. 2006;12(4):539–545.
   PubMed Web of Science ®Google Scholar
• Kakafika A, Papadopoulos V, Mimidis K, et al. Coagulation, platelets, and acute pancreatitis. Pancreas. 2007;34(1):15–20.
   PubMed Web of Science ®Google Scholar
• Wang F, Meng Z, Li S, et al. Platelet distribution width levels can be a predictor in the diagnosis of persistent organ failure in acute pancreatitis. Gastroenterol Res Pract. 2017;2017:1–6.
   Web of Science ®Google Scholar
• Shetty SK, Naik R, Shetty AS, et al. Acute pancreatitis - the current concept in ethiopathogenesis, morphology and complications. In: Rodrigo L, editor. Pancreatitis-Treatment and Complications. London (UK): IntechOpen; 2012. p. 3–12.
   Google Scholar
• Steer ML. Pathogenesis of acute pancreatitis. Digestion. 1997;58(Suppl 1):46–49.
   PubMed Web of Science ®Google Scholar
• Sah RP, Saluja A. Molecular mechanisms of pancreatic injury. Curr Opin Gastroenterol. 2011;27(5):444–4451.
   PubMed Web of Science ®Google Scholar
• Gukovskaya AS, Gukovsky I, Algül H, et al. Autophagy, inflammation, and immune dysfunction in the pathogenesis of pancreatitis. Gastroenterology. 2017;153(5):1212–1226.
   PubMed Web of Science ®Google Scholar
• Gukovsky I, Pandol SJ, Mareninova OA, et al. Impaired autophagy and organellar dysfunction in pancreatitis. J Gastroenterol Hepatol. 2012;27(Suppl 2):27–32.
   PubMed Web of Science ®Google Scholar
• Rakonczay Z Jr, Hegyi P, Takács T, et al. The role of NF-kappaB activation in the pathogenesis of acute pancreatitis. Gut. 2008;57(2):259–267.
   PubMed Web of Science ®Google Scholar
• Jakkampudi A, Jangala R, Reddy BR, et al. NF-κB in acute pancreatitis: mechanisms and therapeutic potential. Pancreatology. 2016;16(4):477–488.
   PubMed Web of Science ®Google Scholar
• Habtezion A. Inflammation in acute and chronic pancreatitis. Curr Opin Gastroenterol. 2015;31(5):395–399.
   PubMed Web of Science ®Google Scholar
• Whitcomb DC. Genetic aspects of pancreatitis. Annu Rev Med. 2010;61(1):413–424.
   PubMed Web of Science ®Google Scholar
• Terlizzi V, De Gregorio F, Sepe A, et al. Brand new SPINK1 and CFTR mutations in a child with acute recurrent pancreatitis: a case report. Minerva Pediatr. 2013;65(6):669–672.
   PubMed Web of Science ®Google Scholar
• Koziel D, Gluszek S, Kowalik A, et al. Genetic mutations in SPINK1, CFTR, CTRC genes in acute pancreatitis. BMC Gastroenterol. 2015;15(1):70.
   PubMed Web of Science ®Google Scholar
• Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111.
   PubMed Web of Science ®Google Scholar
• Manrai M, Kochhar R, Thandassery R, et al. The revised Atlanta classification of acute pancreatitis: a work still in progress? Limitations of the original atlanta classification. JOP. 2015;16:356–364.
   Google Scholar
• van Dijk SM, Hallensleben NDL, van Santvoort HC, et al. Acute pancreatitis: recent advances through randomised trials. Gut. 2017;66(11):2024–2032.
   PubMed Web of Science ®Google Scholar
• Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2002;9(4):401–410.
   PubMedGoogle Scholar
• Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–1415.
   PubMed Web of Science ®Google Scholar
• Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1–15.
   PubMed Web of Science ®Google Scholar
• Crockett SD, Wani S, Gardner TB, et al. American gastroenterological association institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018;154(4):1096–1101.
   PubMed Web of Science ®Google Scholar
• Schorn S, Ceyhan GO, Tieftrunk E, et al. Pain management in acute pancreatitis [Internet]. 2015 [cited 2021 Oct 29. Available from: https://www.pancreapedia.org/reviews/pain-management-in-acute-pancreatitis
   Google Scholar
• Basurto Ona X, Rigau Comas D, Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013;7:1–33.
   Google Scholar
• Arvanitakis M, Ockenga J, Bezmarevic M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2020;39(3):612–631.
   PubMed Web of Science ®Google Scholar
• Besselink MG, van Santvoort HC, Boermeester MA, et al. Timing and impact of infections in acute pancreatitis. Br J Surg. 2009;96(3):267–273.
   PubMed Web of Science ®Google Scholar
• Jiang X, Shi JY, Wang XY, et al. The impacts of infectious complications on outcomes in acute pancreatitis: a retrospective study. Mil Med Res. 2020;7(1):38.
   PubMed Web of Science ®Google Scholar
• Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386(9988):85–96.
   PubMed Web of Science ®Google Scholar
• Johnson CD. Antioxidants in acute pancreatitis. Gut. 2007;56(10):1344–1345.
   PubMed Web of Science ®Google Scholar
• García-Lafuente A, Guillamón E, Villares A, et al. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res. 2009;58(9):537–552.
   PubMed Web of Science ®Google Scholar
• Lampropoulos P, Lambropoulou M, Papalois A, et al. The role of apigenin in an experimental model of acute pancreatitis. J Surg Res. 2013;183(1):129–137.
   PubMed Web of Science ®Google Scholar
• Charalabopoulos A, Davakis S, Lambropoulou M, et al. Apigenin exerts anti-inflammatory effects in an experimental model of acute pancreatitis by down-regulating TNF-α. Vivo. 2019;33(4):1133–1141.
   PubMed Web of Science ®Google Scholar
• Yildirim AO, Ince M, Eyi YE, et al. The effects of glycyrrhizin on experimental acute pancreatitis in rats. Eur Rev Med Pharmacol Sci. 2013;17(22):2981–2987.
   PubMed Web of Science ®Google Scholar
• Pan YL. The effects of glycyrrhizin on acute pancreatitis in mice. Eur Rev Med Pharmacol Sci. 2014;18(24):3943–3947.
   PubMed Web of Science ®Google Scholar
• Scott P, Bruce C, Schofield D, et al. Vitamin C status in patients with acute pancreatitis. Br J Surg. 2005;80(6):750–754.
   Web of Science ®Google Scholar
• Siriwardena AK, Mason JM, Balachandra S, et al. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut. 2007;56(10):1439–1444.
   PubMed Web of Science ®Google Scholar
• Arutla M, Raghunath M, Deepika G, et al. Efficacy of enteral glutamine supplementation in patients with severe and predicted severe acute pancreatitis- A randomized controlled trial. Indian J Gastroenterol. 2019;38(4):338–3347.
   PubMed Web of Science ®Google Scholar
• Jeurnink SM, Nijs MM, Prins HA, et al. Antioxidants as a treatment for acute pancreatitis: a meta-analysis. Pancreatology. 2015;15(3):203–208.
   PubMed Web of Science ®Google Scholar
• Dumnicka P, Maduzia D, Ceranowicz P, et al. The interplay between inflammation, coagulation and endothelial injury in the early phase of acute pancreatitis: clinical implications. Int J Mol Sci. 2017;18(2):354.
   PubMed Web of Science ®Google Scholar
• Salas A, Sans M, Soriano A, et al. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut. 2000;47(1):88–96.
   PubMed Web of Science ®Google Scholar
• Tozlu M, Kayar Y, İnce AT, et al. Low molecular weight heparin treatment of acute moderate and severe pancreatitis: a randomized, controlled, open-label study. Turk J Gastroenterol. 2019;30(1):81–87.
   PubMed Web of Science ®Google Scholar
• Xu X, Dai Y. Heparin: an intervenor in cell communication. J Cell Mol Med. 2010;14(1–2):175–180.
   PubMed Web of Science ®Google Scholar
• Evangelista V, Piccardoni P, Maugeri N, et al. Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G. Eur J Pharmacol. 1992;216(3):401–405.
   PubMed Web of Science ®Google Scholar
• Qiu Q, Li GJ, Tang L, et al. The efficacy of low molecular weight heparin in severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. J Dig Dis. 2019;20(10):512–522.
   PubMed Web of Science ®Google Scholar
• Kyhälä L, Lindström O, Kylänpää L, et al. Activated protein C retards recovery from coagulopathy in severe acute pancreatitis. Scand J Clin Lab Invest. 2016;76(1):10–16.
   PubMed Web of Science ®Google Scholar
• Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ. 2019;367:l6227.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Treating acute pancreatitis with dabigatran, a pilot study [Internet]. [cited 2021 Oct 29]. Available from: https://clinicaltrials.gov/ct2/show/NCT03807856?term=NCT03807856&draw=2&rank=1
   Google Scholar
• Kitagawa M, Hayakawa T. Antiproteases and the pancreas: basic and clinical update. Conclusion remarks. JOP. 2007;8(4 Suppl):538–544.
   PubMedGoogle Scholar
• Lagoo JY, D’Souza MC, Kartha A, et al. Role of Ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: a retrospective analysis. J Crit Care. 2018;45:27–32.
   PubMed Web of Science ®Google Scholar
• He HW, Zhang H. The efficacy of different doses of ulinastatin in the treatment of severe acute pancreatitis. Ann Palliat Med. 2020;9(3):730–737.
   PubMed Web of Science ®Google Scholar
• Pan Y, Fang H, Lu F, et al. Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells. J Inflamm (Lond). 2017;14(1):7.
   PubMed Web of Science ®Google Scholar
• NL LC, Cui X. Ulinastatin combined with somatostatin improves intestinal function recovery and treatment efficiency in severe acute pancreatitis. Int J Clin Exp Med. 2020;13(2):766–773.
   Web of Science ®Google Scholar
• JS XR, Zhou H, Jin W. Clinical efficacy of ulinastatin combined with somatostatin for treatment of severe acute pancreatitis and effects on immune function. Int J Clin Exp Med. 2019;12(9):11333–11341.
   Web of Science ®Google Scholar
• Chen H-M, Hwang T-L, Chen M-F. The effect of gabexate mesilate on pancreatic and hepatic microcirculation in acute experimental pancreatitis in rats. J Surg Res. 1996;66(2):147–153.
   PubMed Web of Science ®Google Scholar
• Wang G, Liu Y, Zhou SF, et al. Effect of somatostatin, ulinastatin and gabexate on the treatment of severe acute pancreatitis. Am J Med Sci. 2016;351(5):506–512.
   PubMed Web of Science ®Google Scholar
• Kambhampati S, Park W, Habtezion A. Pharmacologic therapy for acute pancreatitis. World J Gastroenterol. 2014;20(45):16868–16880.
   PubMed Web of Science ®Google Scholar
• Heintges T, Lüthen R, Niederau C. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues. Digestion. 1994;55(Suppl. 1):1–9.
   PubMed Web of Science ®Google Scholar
• Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharm. 1989;8(4):255–273.
   PubMedGoogle Scholar
• Rai U, Thrimawithana TR, Valery C, et al. Therapeutic uses of somatostatin and its analogues: current view and potential applications. Pharmacol Ther. 2015;152:98–110.
   PubMed Web of Science ®Google Scholar
• Bang UC, Semb S, Nojgaard C, et al. Pharmacological approach to acute pancreatitis. World J Gastroenterol. 2008;14(19):2968–2976.
   PubMed Web of Science ®Google Scholar
• Banks PA, Conwell DL, Toskes PP. The management of acute and chronic pancreatitis. Gastroenterol Hepatol. 2010;6(2 Suppl 3):1–16.
   Google Scholar
• Munir F, Jamshed MB, Shahid N, et al. Advances in immunomodulatory therapy for severe acute pancreatitis. Immunol Lett. 2020;217:72–76.
   PubMed Web of Science ®Google Scholar
• Johnson CD, Kingsnorth AN, Imrie CW, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut. 2001;48(1):62–69.
   PubMed Web of Science ®Google Scholar
• Vege SS, Atwal T, Bi Y, et al. Pentoxifylline treatment in severe acute pancreatitis: a pilot, double-blind, placebo-controlled, randomized trial. Gastroenterology. 2015;149(2):318–320.
   PubMed Web of Science ®Google Scholar
• Vege SS, Horibe M, Chari ST, et al. A single center randomized double blind controlled trial of pentoxifylline in acute pancreatitis: challenges and opportunities. Pancreatology. 2020;20(8):1592–1597.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Randomised treatment of acute pancreatitis with infliximab: double-blind multi-centre trial (RAPID-I) (RAPID-I) [Internet]. cited 2021 Oct 29. Available from: https://clinicaltrials.gov/ct2/show/NCT03684278?term=NCT03684278&draw=2&rank=1
   Google Scholar
• Mukherjee R, Nunes Q, Huang W, et al. Precision medicine for acute pancreatitis: current status and future opportunities. Precis clin med. 2019;2(2):81–86.
   PubMedGoogle Scholar
• Ahmed SM, Morsi M, Ghoneim NI, et al. Mesenchymal stromal cell therapy for pancreatitis: a systematic review. Oxid Med Cell Longev. 2018;2018:3250864.
   PubMed Web of Science ®Google Scholar
• Qian D, Wei G, Xu C, et al. Bone marrow-derived mesenchymal stem cells (BMSCs) repair acute necrotized pancreatitis by secreting microRNA-9 to target the NF-κB1/p50 gene in rats. Sci Rep. 2017;7(1):1–17.
   PubMedGoogle Scholar
• ClinicalTrials.gov. Safety and efficacy of SCM-AGH in patients with moderate to severe acute pancreatitis [Internet]. [cited 2021 Oct 29]. Available from: https://clinicaltrials.gov/ct2/show/NCT04189419?term=NCT04189419&draw=2&rank=1
   Google Scholar
• Singh AP, Biswas A, Shukla A, et al. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther. 2019;4(33):1–21.
   PubMed Web of Science ®Google Scholar
• Yao Q, Jiang X, Zhai YY, et al. Protective effects and mechanisms of bilirubin nanomedicine against acute pancreatitis. J Control Release. 2020;322:312–325.
   PubMed Web of Science ®Google Scholar
• Khurana A, Anchi P, Allawadhi P, et al. Yttrium oxide nanoparticles reduce the severity of acute pancreatitis caused by cerulein hyperstimulation. Nanomedicine. 2019;18:54–65.
   PubMed Web of Science ®Google Scholar
• Pallagi P, Madácsy T, Varga Á, et al. Intracellular Ca(2+) signalling in the pathogenesis of acute pancreatitis: recent advances and translational perspectives. Int J Mol Sci. 2020;21(11):1–19.
   Web of Science ®Google Scholar
• Waldron RT, Chen Y, Pham H, et al. The Orai Ca(2+) channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis. J Physiol. 2019;597(12):3085–3105.
   PubMed Web of Science ®Google Scholar
• Bruen C, Miller J, Wilburn J, et al. Auxora for the treatment of patients with acute pancreatitis and accompanying systemic inflammatory response syndrome: clinical development of a calcium release-activated calcium channel inhibitor. Pancreas. 2021;50(4):537–543.
   PubMed Web of Science ®Google Scholar
• BC MJ, Wilburn J, Mackey C, et al. 353 an open-label, dose-response study of CM4620-injectable emulsion in emergency department patients with acute pancreatitis. Ann Emerg Med. 2019;74(4):S138–139.
   Web of Science ®Google Scholar
• ClinicalTrials.gov. A study of auxora in patients with acute pancreatitis and accompanying SIRS (CARPO) [Internet]. [cited 2021 Dec 8. Available from: https://clinicaltrials.gov/ct2/show/NCT04681066
   Google Scholar
• ClinicalTrials.gov. Study of CM4620 to reduce the severity of pancreatitis due to asparaginase [Internet]. [cited 2021 Oct 29]. Available from: https://clinicaltrials.gov/ct2/show/NCT04195347?term=NCT04195347&draw=2&rank=1
   Google Scholar
• Xiao J, Feng X, Huang XY, et al. Spautin-1 ameliorates acute pancreatitis via inhibiting impaired autophagy and alleviating calcium overload. Mol Med. 2016;22(1):643–652.
   PubMed Web of Science ®Google Scholar
• Dong K, Chen X, Xie L, et al. Spautin-A41 attenuates cerulein-induced acute pancreatitis through inhibition of dysregulated autophagy. Biol Pharm Bull. 2019;42(11):1789–1798.
   PubMed Web of Science ®Google Scholar
• Dong LH, Liu ZM, Wang SJ, et al. Corticosteroid therapy for severe acute pancreatitis: a meta-analysis of randomized, controlled trials. Int J Clin Exp Pathol. 2015;8(7):7654–7660.
   PubMed Web of Science ®Google Scholar
• Wang M, Jiang Z, Liang H. Glucocorticoids in acute pancreatitis: a propensity score matching analysis. BMC Gastroenterol. 2021;21(1):1–9.
   PubMed Web of Science ®Google Scholar
• Ataallah B, Abdulrahman M, Al-Zakhari R, et al. Steroid-induced pancreatitis: a challenging diagnosis. Cureus. 2020;12(7):e8939.
   PubMed Web of Science ®Google Scholar
• Nango D, Nakashima H, Hirose Y, et al. Causal relationship between acute pancreatitis and methylprednisolone pulse therapy for fulminant autoimmune hepatitis: a case report and review of literature. J Pharm Health Care Sci. 2018;4(1):14.
   PubMedGoogle Scholar
• ClinicalTrials.gov. Corticosteroids to reduce inflammation in severe pancreatitis: a randomized, controlled study. [Internet]. [cited 2022 Jul 29]. Available from: https://clinicaltrials.gov/ct2/show/NCT05160506?term=NCT05160506&draw=2&rank=1
   Google Scholar
• Demcsák A, Soós A, Kincses L, et al. Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis - an international cohort study. Pancreatology. 2020;20(7):1323–1331.
   PubMed Web of Science ®Google Scholar
• Zhang S, Han Z, Zhang Y, et al. Proton pump inhibitors were associated with reduced pseudocysts in acute pancreatitis: a multicenter cohort study. Front Pharmacol. 2021;12:1–8.
   Web of Science ®Google Scholar
• Das S, Ganguly A, Ghosh A, et al. Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. Ther Drug Monit. 2012;34(3):242–244.
   PubMed Web of Science ®Google Scholar
• Ocal S, Korkmaz M, Yıldırım AE, et al. Lansoprazole-induced acute pancreatitis. Turk J Gastroenterol. 2014;25(5):582–583.
   PubMed Web of Science ®Google Scholar
• Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet. 2020;396(10252):726–734.
   PubMed Web of Science ®Google Scholar